Inventaire - your friends and communities are your best library

Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.

author

Chien-Ching Hung

2000 -

Shu-Wen Lin

Han-Yueh Kuo

Po-Ren Hsueh

published in: Expert Review of Anti-infective Therapy

date of publication: 2014-03-03

Cites articles 62

Date

Title

Authors

2013-04-01

Long-term prognosis in community-acquired pneumonia

Antonio Anzueto, Marcos I Restrepo, Paola Faverio
2013-03-01

Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?

Thomas M. File
2013-03-04

Clinical effects of gemifloxacin on the delay of tuberculosis treatment
2013-03-01

What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
2012-01-04

Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality

Vicente Corrales-Medina, George Wells
2012-06-20

Community-acquired pneumonia guidelines: a global perspective
2012-04-01

Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia.

Brandi Limbago, Rachel Gorwitz, Valerie Albrecht, EMERGEncy ID NET Study Group
2012-12-01

Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward?
2012-04-16

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis

Lisa Tjosvold, Isabelle N Colmers
2012-12-14

How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?

Richard G. Wunderink
2012-07-01

Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses
2012-01-24

A liquid chromatography-tandem mass spectrometry assay for the determination of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single-dose pharmacokinetic study in healthy Chinese volunt
2012-10-31

The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis
2012-04-16

Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan

Po-Ren Hsueh
2011-02-24

Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
2011-06-28

Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies

Vicente Corrales-Medina, Bill Cameron, Dean A Fergusson
2011-05-01

Diagnostic tests for agents of community-acquired pneumonia
2011-11

Guidelines for the management of adult lower respiratory tract infections--full version
2011-02-22

Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species

Po-Ren Hsueh
2011-01-24

Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan

Po-Ren Hsueh
2010-10-08

Management of community-acquired pneumonia: a review and update
2010-03-01

Burden of community-acquired pneumonia in North American adults

Thomas M. File
2010-12-01

Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005.
2010-11-10

Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia

Donald E Low, Thomas M. File
2010-03-22

Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States

Helio S Sader, Ronald N Jones
2010-05-01

Levofloxacin in the treatment of community-acquired pneumonia

Walid El-Khatib
2010-01-11

Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates
2010-07-25

In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007

Ping-Ing Lee, Jyh-Chin Yang, Po-Ren Hsueh
2010-09-21

In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone
2010-07-26

Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia
2010-01-01

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

Christian Giske
2009-11-01

Clinical policy: critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia

Scott D Weingart, Wyatt W Decker

Article - wd:Q46887329

Welcome to Inventaire

the library of your friends and communities

learn more